Literature DB >> 7843769

Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta.

C F Küng1, T F Lüscher.   

Abstract

We analyzed the effects and mechanisms of aging in aortic endothelium and vascular smooth muscle of 12-week-old (adult) and 72-week-old (senescent) normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). Aortas were suspended in organ chambers filled with physiological salt solution (95% O2/5% CO2; 37 degrees C), and isometric tension was measured. In WKY, endothelium-dependent relaxations to acetylcholine were diminished with aging (P < .05); in SHR, they were reduced compared with WKY (P < .05) but unchanged with aging. The thromboxane/endoperoxide receptor antagonist SQ 30741 increased relaxations only in adult SHR. Relaxations to sodium nitroprusside were slightly enhanced with age in WKY and SHR (P < .05). Endothelium-dependent contractions to acetylcholine were unmasked by NG-nitro-L-arginine methyl ester (P < .05) and prevented by SQ 30741 or endothelium removal. In WKY, contractions increased with age. In adult SHR, marked endothelium-dependent contractions occurred (P < .05 versus WKY), which diminished with age (P = NS versus senescent WKY). The thromboxane analogue U46619 elicited similar contractions in adult and senescent WKY and adult SHR, whereas responses in senescent SHR were weaker (P < .05). In WKY and SHR, contractions to norepinephrine were similar and unaltered by aging. In WKY, contractions to endothelin-1 remained unaffected by aging. Adult SHR exhibited contractions to endothelin-1 comparable to those in WKY, whereas senescent SHR contracted less (P < .05). Bosentan, a combined endothelin-A/endothelin-B receptor antagonist, inhibited endothelin-1 markedly, especially in SHR (P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843769     DOI: 10.1161/01.hyp.25.2.194

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  44 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

Review 2.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  Pulse pressure, arterial stiffness, and end-organ damage.

Authors:  Michel E Safar; Peter M Nilsson; Jacques Blacher; Albert Mimran
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

4.  Endothelial modulation of alpha 1-adrenoceptor contractile responses in the tail artery of spontaneously hypertensive rats.

Authors:  A Tabernero; J Giraldo; N M Vivas; A Badia; E Vila
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

5.  Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids.

Authors:  R L Matz; M A de Sotomayor; C Schott; J C Stoclet; R Andriantsitohaina
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

6.  [Vessel aging. The role of oxidative stress and protein glycation].

Authors:  A Simm
Journal:  Z Gerontol Geriatr       Date:  2011-06       Impact factor: 1.281

7.  PPARα ligand clofibrate ameliorates blood pressure and vascular reactivity in spontaneously hypertensive rats.

Authors:  Zivar Yousefipour; Mohammad Newaz
Journal:  Acta Pharmacol Sin       Date:  2014-02-24       Impact factor: 6.150

8.  Aldose reductase and AGE-RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats.

Authors:  Kellie McCormick Hallam; Qing Li; Radha Ananthakrishnan; Anastasia Kalea; Yu S Zou; Srinivasan Vedantham; Ann Marie Schmidt; Shi Fang Yan; Ravichandran Ramasamy
Journal:  Aging Cell       Date:  2010-08-15       Impact factor: 9.304

9.  Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation.

Authors:  Pál Pacher; Jon G Mabley; Francisco G Soriano; Lucas Liaudet; Katalin Komjáti; Csaba Szabó
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 10.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.